Thrombosis and Coagulopathy in COVID-19: Current Understanding and Implications for Antithrombotic Treatment in Patients Treated With Percutaneous Coronary Intervention

Thrombosis and Coagulopathy in COVID-19: Current Understanding and Implications for Antithrombotic Treatment in Patients Treated With Percutaneous Coronary Intervention

Coronavirus disease 2019 (COVID-19), a respiratory syndrome, is a global pandemic. Therefore, there is an urgent need to explore mechanisms implicated in the pathogenesis of the disease. Clinical and autopsy studies show a complex chain of events preceding COVID-19-related death. The disease is char...

Full description

Bibliographic Details
Main Authors: Hangkuan Liu, Zhijia Wang, Haonan Sun, Tianming Teng, Yongle Li, Xin Zhou, Qing Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
COVID-19
thrombosis
coagulopathy
antithrombotic treatment
percutaneous coronary intervention
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2020.599334/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2020.599334/full

Similar Items